We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Sabre
SABR
$739M
| $5M | 0.01% |
235,757
+8,965
| +4% | +$205K |
|
|
GWB
1002
DELISTED
Great Western Bancorp, Inc.
GWB
| $4.99M | 0.01% |
117,646
+32,947
| +39% | +$1.42M |
|
|
SIX
1003
DELISTED
Six Flags Entertainment Corp.
SIX
| $4.97M | 0.01% |
83,619
+2,700
| +3% | +$162K |
|
1004
Mine Safety
MSA
$6.73B
| $4.97M | 0.01% |
70,328
+2,679
| +4% | +$187K |
|
1005
Moog Inc Class A
MOG.A
$13.3B
| $4.97M | 0.01% |
73,728
+17,700
| +32% | +$1.17M |
|
1006
J&J Snack Foods
JJSF
$1.44B
| $4.96M | 0.01% |
36,554
+8,177
| +29% | +$1.08M |
|
1007
Assured Guaranty
AGO
$3.73B
| $4.95M | 0.01% |
133,482
+6,311
| +5% | +$250K |
|
1008
American Homes 4 Rent
AMH
$11.9B
| $4.92M | 0.01% |
214,493
+22,823
| +12% | +$510K |
|
1009
Avis
CAR
$5.37B
| $4.9M | 0.01% |
165,647
+776
| +0.5% | +$26.9K |
|
1010
United Natural Foods
UNFI
$3.01B
| $4.9M | 0.01% |
113,325
+2,616
| +2% | +$118K |
|
|
BLUE
1011
DELISTED
bluebird bio
BLUE
| $4.89M | 0.01% |
4,152
+365
| +10% | +$372K |
|
1012
Huntsman Corp
HUN
$2.12B
| $4.89M | 0.01% |
199,098
+11,417
| +6% | +$246K |
|
|
ILG
1013
DELISTED
ILG, Inc Common Stock
ILG
| $4.88M | 0.01% |
233,050
+23,530
| +11% | +$443K |
|
|
BID
1014
DELISTED
Sotheby's
BID
| $4.86M | 0.01% |
106,931
+1,562
| +1% | +$66.8K |
|
1015
Old National Bancorp
ONB
$10.1B
| $4.86M | 0.01% |
280,215
+75,205
| +37% | +$1.34M |
|
1016
Graham Holdings Company
GHC
$5.28B
| $4.86M | 0.01% |
8,108
+416
| +5% | +$227K |
|
|
HA
1017
DELISTED
Hawaiian Holdings, Inc.
HA
| $4.86M | 0.01% |
104,568
+30,096
| +40% | +$1.54M |
|
|
LTC
1018
LTC Properties
LTC
$2.06B
| $4.85M | 0.01% |
101,190
+25,446
| +34% | +$1.19M |
|
1019
Mueller Industries
MLI
$14.8B
| $4.84M | 0.01% |
565,620
+139,576
| +33% | +$1.36M |
|
1020
Alnylam Pharmaceuticals
ALNY
$27.5B
| $4.84M | 0.01% |
94,411
+4,028
| +4% | +$186K |
|
1021
Booz Allen Hamilton
BAH
$8.22B
| $4.82M | 0.01% |
136,236
+10,102
| +8% | +$361K |
|
1022
Genpact
G
$5.99B
| $4.82M | 0.01% |
194,621
+22,314
| +13% | +$544K |
|
1023
Neogen
NEOG
$2.51B
| $4.82M | 0.01% |
195,875
+56,611
| +41% | +$1.39M |
|
|
IBKC
1024
DELISTED
IBERIABANK Corp
IBKC
| $4.81M | 0.01% |
60,859
+5,827
| +11% | +$478K |
|
|
CAB
1025
DELISTED
Cabela's Inc
CAB
| $4.81M | 0.01% |
90,551
+4,745
| +6% | +$243K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.